The Value of Repeat 5-HIAA Measurements as a Predictor of Carcinoid Heart Disease: A Prospective 5-Year Follow-Up Study in Patients with Small Intestinal Neuroendocrine Tumors [PDF]
Cancers (Basel)Simple Summary Small intestinal neuroendocrine tumors (SI-NETs) can lead to carcinoid syndrome and carcinoid heart disease (CHD). In this prospective study we aimed to identify early risk markers for CHD and mortality in patients with SI-NETs.
Iiro Kostiainen +8 more
semanticscholar +2 more sources
Quadruple Valve Replacement in Carcinoid Heart Disease: A Case Report [PDF]
Cureus, 2023 This report details a rare case of left-sided carcinoid heart disease (CHD). In CHD, vasoactive substances released from carcinoid tumors cause fibrous tissue formation on the right side of the heart. These substances are usually inactivated by monoamine
Maria Beyer +3 more
semanticscholar +2 more sources
Artificial intelligence-augmented analysis of contemporary procedural, mortality, and cost trends in carcinoid heart disease in a large national cohort with a focus on the “forgotten pulmonic valve” [PDF]
Frontiers in Cardiovascular Medicine, 2023 Background Carcinoid heart disease is increasingly recognized and challenging to manage due to limited outcomes data. This is the largest known cohort study of valvular pathology, treatment (including pulmonary and tricuspid valve replacements [PVR and ...
Dominique Monlezun +19 more
openalex +2 more sources
Metastatic well differentiated serotonin-producing pancreatic neuroendocrine tumor with carcinoid heart disease: a case report [PDF]
J Gastrointest Oncol, 2023 Background Less than two percent of pancreatic neuroendocrine tumors (NETs) produce serotonin. Serotonin can cause carcinoid syndrome and less commonly carcinoid heart disease (CHD).
M. Kudelka +10 more
semanticscholar +2 more sources
Molecular biology of carcinoid heart disease: Seeking therapeutic targets in the era of targeted therapy [PDF]
Medicine (Baltimore), 2023 Carcinoid tumors (CT) are among the least studied tumors. It is a relatively rare and slow-growing tumor with good survival in its primary form. However, metastatic carcinoid tumor comes up with many different complications contributing to increased ...
S. A. Khan +6 more
semanticscholar +2 more sources
Late-stage diagnosis of carcinoid heart disease due to lack of access to health care [PDF]
Cardiooncology, 2023 Carcinoid syndrome (CS) is a unique constellation of symptoms caused by release of vasoactive substances from neuroendocrine tumors (Pandit et al., StatPearls, 2022).
Aditi Sharma +6 more
semanticscholar +2 more sources
The Role of Transthoracic Echocardiography for Assessment of Mortality in Patients with Carcinoid Heart Disease Undergoing Valve Replacement [PDF]
Cancers (Basel), 2023 Simple Summary A proportion of patients with neuroendocrine tumours develop carcinoid syndrome and subsequent carcinoid heart disease (CHD). Valve replacement is indicated for patients with CHD when there is severe regurgitation and symptoms or evidence ...
A. Brooke +9 more
semanticscholar +2 more sources
Analysis of Patients with NET G1/G2 Neuroendocrine Tumors of the Small Intestine in the Course of Carcinoid Heart Disease—A Retrospective Study [PDF]
J Clin Med, 2023 Neuroendocrine neoplasms of the small intestine (SI-NENs) are one of the most commonly recognized gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs).
Sonia J Konsek-Komorowska +6 more
semanticscholar +2 more sources
Multimodality imaging in the diagnostic approach to a patient with carcinoid heart disease involving four heart valves [PDF]
Clinical Case Reports, 2022 Carcinoid heart disease is a rare condition that occurs in less than half of patients with carcinoid syndrome. The disease mainly affects right‐sided heart valves; however, in 5%–10%, it can also involve left‐sided valves.
Shirin Habibi Khorasani +6 more
doaj +2 more sources
Simultaneous surgical treatment of primary ovarian carcinoid and carcinoid heart disease [PDF]
Polish Journal of Thoracic and Cardiovascular Surgery, 2022 The incidence of neuroendocrine tumors (NET) is 2.5–5 per 100 000 population. Up to 20% of patients with NET develop carcinoid syndrome (CS), and in 40–50% of those carcinoid heart disease (CHD) is reported (0.27 per 100 000 population per year) [1 ...
Uladzimir Andrushchuk +3 more
doaj +2 more sources